Integra LifeSciences Forecasts Fiscal Year 2024 Revenues Of $1.603B-$1.618B, Representing Reported And Organic Growth Of Approximately 4.0%-5.0%, Versus Consensus Of $1.62B
Portfolio Pulse from Benzinga Newsdesk
Integra LifeSciences projects FY 2024 revenues to be between $1.603B and $1.618B, indicating a growth of 4.0%-5.0%, which is slightly below the consensus estimate of $1.62B.
February 28, 2024 | 11:06 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Integra LifeSciences forecasts FY 2024 revenues to be slightly below consensus estimates, projecting growth of 4%-5%.
The projected revenue for FY 2024 by Integra LifeSciences is slightly below the consensus estimates, which could lead to a negative perception among investors and potentially impact the stock price negatively in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100